WallStreetZenWallStreetZen

NASDAQ: PLRX
Pliant Therapeutics Inc Stock Ownership - Who owns Pliant Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pliant Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mike OuimetteGeneral Counsel Corp. Secy2025-01-2210,230$10.99
$112.46kSell
Bernard CouliePresident and CEO2025-01-1752,419$11.20
$587.15kSell
Lily CheungChief Human Resource Officer2025-01-173,740$11.20
$41.89kSell
Keith Lamont CummingsChief Financial Officer2025-01-1720,148$11.20
$225.68kSell
Hans HullChief Business Officer2025-01-1715,936$11.20
$178.50kSell
Eric LefebvreChief Medical Officer2025-01-1718,478$11.20
$206.97kSell
Mike OuimetteGeneral Counsel Corp. Secy2025-01-1713,270$11.20
$148.64kSell
Mike OuimetteGeneral Counsel Corp. Secy2024-07-107,656$11.56
$88.50kSell
Eric LefebvreChief Medical Officer2024-07-1012,319$11.56
$142.41kSell
Keith Lamont CummingsChief Financial Officer2024-07-1010,911$11.56
$126.13kSell

1 of 2

PLRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLRX insiders and whales buy or sell their stock.

PLRX Shareholders

What type of owners hold Pliant Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matthew G. Robinson26.24%16,069,177$23.62MInsider
Deep Track Capital LP9.75%5,972,257$8.78MInstitution
Blackrock Inc8.46%5,179,977$7.61MInstitution
Price T Rowe Associates Inc7.57%4,634,486$6.81MInstitution
Third Rock Ventures III LP7.34%4,495,238$6.61MInsider
Fmr LLC6.33%3,876,598$5.70MInstitution
Vanguard Group Inc5.27%3,228,755$4.75MInstitution
Paradigm Biocapital Advisors LP5.22%3,197,050$4.70MInstitution
Redmile Group LLC4.73%2,895,478$4.26MInstitution
Blue Owl Capital Holdings LP4.52%2,769,199$4.07MInstitution

1 of 3

PLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PLRX71.14%28.86%Net Selling
BDTX70.39%29.61%Net SellingNet Selling
VTYX45.90%54.10%Net BuyingNet Selling
TCRX73.39%25.38%Net Buying
VIGL41.59%58.41%Net Buying
View Top Biotech Stocks

Pliant Therapeutics Stock Ownership FAQ

Who owns Pliant Therapeutics?

Pliant Therapeutics (NASDAQ: PLRX) is owned by 105.74% institutional shareholders, 42.91% Pliant Therapeutics insiders, and 0.00% retail investors. Matthew G. Robinson is the largest individual Pliant Therapeutics shareholder, owning 16.07M shares representing 26.24% of the company. Matthew G. Robinson's Pliant Therapeutics shares are currently valued at $23.78M.

If you're new to stock investing, here's how to buy Pliant Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.